Real-time three-dimensional systolic dyssynchrony index predicts pacing-induced left ventricular dysfunction and

Moustafa Dawood1, Hoda Abdelgawad2,3, Aly Aboelhoda2

  • 1Faculty of Medicine, Alexandria University, Alexandria, Egypt. moustafadawood@yahoo.com.

Insights

Early measurement of systolic dyssynchrony index (SDI) using real-time three-dimensional echocardiography (RT3DE) can predict pacing-induced left ventricular (LV) dysfunction. This assessment within a week of pacemaker implantation aids in risk stratification and preventing cardiomyopathy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Right ventricular pacing can cause left ventricular (LV) dyssynchrony, a key factor in pacing-induced LV dysfunction (PIVD) and cardiomyopathy (PICM).
  • Early identification of patients at risk for PIVD and PICM is crucial for timely intervention.

Purpose of the Study:

  • To determine the incidence of PIVD and PICM.
  • To evaluate the prognostic value of the real-time three-dimensional echocardiography (RT3DE)-derived systolic dyssynchrony index (SDI) in predicting PIVD and PICM development shortly after pacemaker implantation.

Main Methods:

  • Prospective observational study of 60 patients with preserved baseline LVEF undergoing permanent RV pacing.
  • Echocardiography, including GLS and RT3DE for SDI calculation, performed at baseline, 7-10 days, and 6 months post-implantation.
  • Patients classified at 6 months into preserved, PIVD, or PICM groups based on LVEF changes.

Main Results:

  • 41.7% of patients developed LV impairment (16 PIVD, 9 PICM).
  • Higher SDI and worse GLS at 7-10 days post-pacing were observed in the dysfunction group.
  • Early SDI (≥1.49%) and GLS were independent predictors of 6-month LV dysfunction, with high sensitivity and specificity.

Conclusions:

  • RT3DE-derived SDI is a powerful predictor of pacing-induced LV dysfunction, detectable within the first week post-implantation.
  • Early SDI measurement allows for risk stratification and guided interventions to prevent progression to cardiomyopathy.
Abstract